Healthy volunteers help test new Drug's safety and processing

NCT ID NCT07297940

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This early-stage trial studied how the drug DA-1229_01 is absorbed and processed in 42 healthy adults. Participants received a single dose of the drug in two different forms, and researchers measured drug levels in the blood. The goal was to check safety and how the body handles the drug, not to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

DA-1229_01 (a drug being tested for how the body absorbs and processes it)

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Locations

  • Bumin hospital

    Seoul, South Korea